Veradigm advances AI use in hormone therapy and cardiovascular care for menopausal women

Veradigm advances AI use in hormone therapy and cardiovascular care for menopausal women
Veradigm brings AI to menopause care

Veradigm is set to deliver a series of presentations focusing on hormone replacement therapy, cardiovascular risk, and the transformative role of real world data and artificial intelligence in healthcare for peri and postmenopausal women.

The event aims to deepen understanding of how technology-driven insights can shape more effective care strategies for women experiencing menopause, spotlighting the intersection of cardiology and advanced analytics within clinical practice.

Veradigm previously gathered public health and IT experts at HIMSS 26 to advance discussions on surveillance and EHRs for public health. The company also kicked off RISE National in Orlando to drive forward-thinking strategies for the Medicare Advantage sector. The latest series of presentations expands Veradigm’s focus on applying data and technology in healthcare.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.